Total Payments
$1.1M
2024 Payments
$56,183
Companies
73
Transactions
3,445
Medicare Patients
4,667
Medicare Billing
$518,899
Payment Breakdown by Category
Other$990,205 (86.3%)
Travel$95,597 (8.3%)
Food & Beverage$60,099 (5.2%)
Education$965.44 (0.1%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $980,570 | 442 | 85.5% |
| Travel and Lodging | $95,597 | 234 | 8.3% |
| Food and Beverage | $60,099 | 2,716 | 5.2% |
| Honoraria | $9,635 | 2 | 0.8% |
| Education | $965.44 | 50 | 0.1% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $370,499 | 919 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $200,162 | 274 | $0 (2024) |
| Amgen Inc. | $186,516 | 291 | $0 (2024) |
| Amarin Pharma Inc. | $121,285 | 316 | $0 (2023) |
| Insulet Corporation | $121,124 | 202 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $42,423 | 96 | $0 (2024) |
| Valeritas, Inc. | $37,225 | 81 | $0 (2019) |
| Corcept Therapeutics | $21,358 | 109 | $0 (2024) |
| Mannkind Corporation | $9,305 | 47 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $9,163 | 41 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,183 | 307 | Bayer Healthcare Pharmaceuticals Inc. ($25,301) |
| 2023 | $23,369 | 275 | Bayer Healthcare Pharmaceuticals Inc. ($12,202) |
| 2022 | $47,572 | 362 | Novo Nordisk Inc ($36,376) |
| 2021 | $55,196 | 301 | Novo Nordisk Inc ($41,565) |
| 2020 | $178,428 | 349 | Insulet Corporation ($119,283) |
| 2019 | $254,598 | 522 | Novo Nordisk Inc ($83,452) |
| 2018 | $282,811 | 618 | Novo Nordisk Inc ($85,791) |
| 2017 | $248,768 | 711 | Novo Nordisk Inc ($79,021) |
All Payment Transactions
3,445 individual payment records from CMS Open Payments — Page 1 of 138
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Durable Pump | ||||||
| 12/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $17.23 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/13/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $126.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | RECORDATI_RARE_DISEASES_INC. | ISTURISA (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Rare Disease | ||||||
| 12/02/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | Corcept Therapeutics | Korlym (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: Endocrinology | ||||||
| 11/26/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: Insulin Pump | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 926 | 1,493 | $191,446 | $104,807 |
| 2022 | 5 | 1,032 | 1,707 | $205,970 | $110,767 |
| 2021 | 5 | 1,244 | 2,245 | $274,437 | $152,995 |
| 2020 | 4 | 1,465 | 2,642 | $335,282 | $150,330 |
Total Patients
4,667
Total Services
8,087
Medicare Billing
$518,899
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 562 | $85,424 | $48,512 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 462 | 758 | $78,074 | $43,324 | 55.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 78 | 78 | $18,201 | $8,875 | 48.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $5,700 | $2,658 | 46.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 35 | 57 | $4,047 | $1,438 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 622 | 1,161 | $119,583 | $63,557 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 294 | 425 | $64,600 | $36,707 | 56.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $13,980 | $7,060 | 50.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $6,600 | $3,036 | 46.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 12 | 17 | $1,207 | $406.95 | 33.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 721 | 1,529 | $157,487 | $91,805 | 58.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 327 | 520 | $79,040 | $42,618 | 53.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 113 | 113 | $26,329 | $13,229 | 50.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 72 | 72 | $10,800 | $5,044 | 46.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 11 | 11 | $781.00 | $299.86 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 757 | 1,609 | $165,727 | $72,862 | 44.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 462 | 787 | $119,624 | $54,959 | 45.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 157 | 157 | $36,581 | $16,559 | 45.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 89 | 89 | $13,350 | $5,951 | 44.6% |
About Dr. Hisham Alrefai, MD
Dr. Hisham Alrefai, MD is a Internal Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811962350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hisham Alrefai, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $56,183 received in 2024. These payments were reported across 3,445 transactions from 73 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($980,570).
As a Medicare-enrolled provider, Alrefai has provided services to 4,667 Medicare beneficiaries, totaling 8,087 services with total Medicare billing of $518,899. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Louisville, KY
- Active Since 02/20/2006
- Last Updated 02/09/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811962350
Products in Payments
- Repatha (Biological) $186,182
- FARXIGA (Drug) $157,842
- Vascepa (Drug) $121,285
- Omnipod (Device) $121,124
- Ozempic (Drug) $114,817
- Tresiba (Drug) $103,552
- RYBELSUS (Drug) $47,826
- Kerendia (Drug) $42,423
- BYDUREON (Drug) $42,077
- V-GO (Device) $37,256
- Victoza (Drug) $28,224
- Rybelsus (Drug) $27,010
- Xultophy 100/3.6 (Drug) $24,464
- Korlym (Drug) $21,358
- AFREZZA (Drug) $9,305
- t-slim insulin pump (Device) $8,913
- Synthroid (Drug) $7,098
- MINIMED 770G (Device) $2,352
- JARDIANCE (Drug) $976.14
- UNITHROID (Drug) $877.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Internal Medicine $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Internal Medicine $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Internal Medicine $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Internal Medicine $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400
Internal Medicine $158,400
Timothy Franxman, M.d, M.D
Internal Medicine — Payments: $140,459
Internal Medicine $140,459